All Insights

Employment and pensions

UK Public Service Pensions Update | February 2025

Welcome to the latest edition of the UK Public Service Pensions Update
Energy and Energy Transition

The Energy Transition | Ofgem announces preliminary approval of grid connection reforms

Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero.
Regulatory and compliance

New NPPS sets out 'value for money' message for UK public procurement

Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability
Employment and pensions

UK Employment Law Coffee Break: Manifesting beliefs, HR pensions spotlight, and a webinar on Belgian employment law reforms

Welcome to our latest Coffee Break in which we look at the latest legal and practical developments impacting UK employers
Life Sciences and Healthcare

Genetic resources, IP and benefits sharing: what changes are ahead internationally?

The WIPO has set out disclosure rules for patent applications as the UN pushes for sharing digital sequence information
Financial Services

International Funds Legal Update | February 2025

Custody and fund service providers face scrutiny, overseas fund regime gets online guide and rule changes for UK UCITS
Energy and Energy Transition

The Energy Transition | UK government plans to approve more nuclear power plants

Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Intellectual property

Copyright in Poland: new difficulties identified for artists and generative AI

What does ZAiKS' reservation of rights for text and data mining mean for artistic professionals and AI systems?
Tax

New coalition in Belgium agrees proposals for major tax reforms

Businesses face a broad range of tax changes that look to address economic competitiveness and growth
Life Sciences and Healthcare

Streamlined reimbursement law looks to boost medicine access in Poland

What can Poland's pharmaceutical industry expect from further reforms due in the second quarter of this year?